Through the partnership with Global fund over 226,508 tuberculosis patients have been
provided with anti TB treatment since 2015. Kenya recently completed TB prevalence survey
to establish the true burden of TB in Kenya and to measure the progress made in TB control.
The results of the survey showed that the burden still remain high with prevalence of 558 per
100,000 and incidence of about 169,000 annually. The Global Fund Grant has enabled
Provision of second line treatment to about 1186 drug resistance tuberculosis cases in the last
3 years including patient support and enrolling patients to NHIF Scheme. New technologies
to aid in diagnosis of TB have been rolled out and Kenya has now close to 200 gene Xpert
machines installed in various health facilities in Counties and National Level.